These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25151391)

  • 21. Ganglioside-Lipid and Ganglioside-Protein Interactions Revealed by Coarse-Grained and Atomistic Molecular Dynamics Simulations.
    Gu RX; Ingólfsson HI; de Vries AH; Marrink SJ; Tieleman DP
    J Phys Chem B; 2017 Apr; 121(15):3262-3275. PubMed ID: 27610460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycolipid and ganglioside metabolism imbalances in Huntington's disease.
    Desplats PA; Denny CA; Kass KE; Gilmartin T; Head SR; Sutcliffe JG; Seyfried TN; Thomas EA
    Neurobiol Dis; 2007 Sep; 27(3):265-77. PubMed ID: 17600724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assays for the analysis of synaptic proteins in neurodegenerative disorders.
    Masliah E; Alford M
    Methods Mol Med; 1999; 22():201-8. PubMed ID: 21380836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Therapeutic Role of Gangliosides in Neurological Disorders.
    Schneider JS
    CNS Drugs; 1994 Mar; 1(3):213-22. PubMed ID: 27520520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human brain gangliosides in development, aging and disease.
    Kracun I; Rosner H; Drnovsek V; Heffer-Lauc M; Cosović C; Lauc G
    Int J Dev Biol; 1991 Sep; 35(3):289-95. PubMed ID: 1814411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of gangliosides: anatomical considerations.
    Emerich DF
    J Neural Transplant Plast; 1992; 3(1):1-19. PubMed ID: 1571395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycolipids of murine lymphocyte subpopulations: a defect in the levels of sialidase-sensitive sialosylated asialo GM1 in beige mouse lymphocytes.
    Schwarting GA; Gajewski A
    J Immunol; 1981 Jun; 126(6):2403-7. PubMed ID: 6971898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol-induced increase of sphingosine recycling for ganglioside biosynthesis: a study performed on cerebellar granule cells in culture.
    Ravasi D; Ferraretto A; Omodeo-salè MF; Tettamanti G; Pitto M; Masserini M
    J Neurosci Res; 2002 Jul; 69(1):80-5. PubMed ID: 12111818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self glycolipids as T-cell autoantigens.
    Shamshiev A; Donda A; Carena I; Mori L; Kappos L; De Libero G
    Eur J Immunol; 1999 May; 29(5):1667-75. PubMed ID: 10359121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
    Duarte-Neves J; Pereira de Almeida L; Cavadas C
    Neurobiol Dis; 2016 Nov; 95():210-24. PubMed ID: 27461050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of metabolism in neurodegenerative disorders.
    Procaccini C; Santopaolo M; Faicchia D; Colamatteo A; Formisano L; de Candia P; Galgani M; De Rosa V; Matarese G
    Metabolism; 2016 Sep; 65(9):1376-90. PubMed ID: 27506744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.
    Hadaczek P; Wu G; Sharma N; Ciesielska A; Bankiewicz K; Davidow AL; Lu ZH; Forsayeth J; Ledeen RW
    Exp Neurol; 2015 Jan; 263():177-89. PubMed ID: 25448159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganglioside Profiling of the Human Retina: Comparison with Other Ocular Structures, Brain and Plasma Reveals Tissue Specificities.
    Sibille E; Berdeaux O; Martine L; Bron AM; Creuzot-Garcher CP; He Z; Thuret G; Bretillon L; Masson EA
    PLoS One; 2016; 11(12):e0168794. PubMed ID: 27997589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance capillary electrophoresis of gangliosides.
    Liu YB; Chan KF
    Electrophoresis; 1991 Jun; 12(6):402-8. PubMed ID: 1889389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gangliosides reduce the development of ethanol dependence without affecting ethanol tolerance.
    Snell LD; Szabó G; Tabakoff B; Hoffman PL
    J Pharmacol Exp Ther; 1996 Oct; 279(1):128-36. PubMed ID: 8858985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides.
    Pan X; De Aragão CBP; Velasco-Martin JP; Priestman DA; Wu HY; Takahashi K; Yamaguchi K; Sturiale L; Garozzo D; Platt FM; Lamarche-Vane N; Morales CR; Miyagi T; Pshezhetsky AV
    FASEB J; 2017 Aug; 31(8):3467-3483. PubMed ID: 28442549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.